Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
出版年份 2016 全文链接
标题
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
作者
关键词
Osteoporosis, Fracture, Treatment, Bisphosphonates, Teriparatide, Strontium ranelate, Denosumab, SERMs, Adherence, Side effects, Non-responder, Male osteoporosis, Drug-induced osteoporosis, Androgen deprivation, Aromatase inhibitors, Length of therapy
出版物
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 39, Issue 7, Pages 807-834
出版商
Springer Nature
发表日期
2016-03-11
DOI
10.1007/s40618-016-0434-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial
- (2015) Nina D. Wagner-Johnston et al. CANCER
- A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
- (2015) Bente L. Langdahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- Bone health in cancer patients: ESMO Clinical Practice Guidelines
- (2014) R. Coleman et al. ANNALS OF ONCOLOGY
- Effect of Clodronate Treatment on Risk of Fracture: A Systematic Review and Meta-analysis
- (2014) B. Frediani et al. CALCIFIED TISSUE INTERNATIONAL
- Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups
- (2014) Jane Burch et al. HEALTH TECHNOLOGY ASSESSMENT
- The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
- (2014) John T. Grbic et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
- (2014) Ivana Sestak et al. LANCET ONCOLOGY
- Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study
- (2014) K. E. Ensrud et al. BMJ-British Medical Journal
- Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology
- (2014) A. M. Isidori et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The effect of zoledronic acid on the fracture risk in men with osteoporosis
- (2014) R. Spiegel et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Treatment of post-menopausal osteoporosis: beyond bisphosphonates
- (2014) S. Ishtiaq et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Biochemical markers of bone turnover – uses and limitations
- (2014) Thinn Thinn Hlaing et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Denosumab and atypical femoral fractures
- (2013) Per Aspenberg Acta Orthopaedica
- Androgens and prostate cancer; pathogenesis and deprivation therapy
- (2013) Mathis Grossmann et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment Thresholds for Osteoporosis and Reimbursability Criteria: Perspectives Associated with Fracture Risk-Assessment Tools
- (2013) Silvano Adami et al. CALCIFIED TISSUE INTERNATIONAL
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
- (2013) Nelson Watts et al. Endocrine Practice
- Denosumab in osteoporosis
- (2013) Dima L Diab et al. Expert Opinion On Drug Safety
- Goal-directed therapy in osteoporosis
- (2013) Eugene McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Renal safety in patients treated with bisphosphonates for osteoporosis: A review
- (2013) Paul D Miller et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Exercise on Treatment-Related Adverse Effects for Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Systematic Review
- (2013) Jason R. Gardner et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) A. Valachis et al. ONCOLOGIST
- Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D
- (2013) S. M. H. Alibhai et al. OSTEOPOROSIS INTERNATIONAL
- Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case–control study in the CPRD
- (2013) C. Cooper et al. OSTEOPOROSIS INTERNATIONAL
- Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate
- (2013) B. Abrahamsen et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Fracture risk assessment
- (2012) Eugene McCloskey et al. CLINICAL BIOCHEMISTRY
- Efficacy of a combined alendronate and calcitriol agent (Maxmarvil^|^reg;) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study
- (2012) Yumie Rhee et al. ENDOCRINE JOURNAL
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
- (2012) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- (2012) Eric Orwoll et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment
- (2012) Jacques Buvat et al. Journal of Sexual Medicine
- Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
- (2012) Angela M Cheung et al. LANCET ONCOLOGY
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?
- (2012) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
- (2012) Steven Boonen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review
- (2012) M. Datta et al. ONCOLOGIST
- Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
- (2012) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Bone-Targeted Agents
- (2012) Alicia K. Morgans et al. UROLOGIC CLINICS OF NORTH AMERICA
- Final 5-year results of Z-FAST trial
- (2011) Adam M. Brufsky et al. CANCER
- Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
- (2011) Antonio Llombart et al. Clinical Breast Cancer
- Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
- (2011) F Jakob et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy
- (2011) Andrea Z. LaCroix JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
- (2011) Laura Y. Park-Wyllie JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis
- (2011) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
- (2011) Matthew Austin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk
- (2011) S. Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atypical Femoral Fractures during Prolonged Use of Bisphosphonates: Short-Term Responses to Strontium Ranelate and Teriparatide
- (2011) N. N. C. Carvalho et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
- (2011) E. T. Middleton et al. OSTEOPOROSIS INTERNATIONAL
- Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
- (2011) J-Y. Reginster et al. OSTEOPOROSIS INTERNATIONAL
- Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg
- (2011) J. D. Wark et al. OSTEOPOROSIS INTERNATIONAL
- Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
- (2011) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- A reappraisal of generic bisphosphonates in osteoporosis
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study
- (2011) K Izumi et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates
- (2010) Isabel Oliveira de Sousa et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Bone disease and skeletal complications in patients with β thalassemia major
- (2010) Rachid Haidar et al. BONE
- Bone Mineral Density and Fracture Rate in Response to Intravenous and Oral Bisphosphonates in Adult Osteogenesis Imperfecta
- (2010) Jay R. Shapiro et al. CALCIFIED TISSUE INTERNATIONAL
- Effects of Two Administration Schemes of Intramuscular Clodronic Acid on Bone Mineral Density
- (2010) Bruno Frediani CLINICAL DRUG INVESTIGATION
- Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis
- (2010) A. John Camm CLINICAL THERAPEUTICS
- Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines
- (2010) Meghan G Donaldson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study
- (2010) Eric S Orwoll et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Management of osteoporosis in postmenopausal women
- (2010) &NA; MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial
- (2010) Steven R. Goldstein et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Lasofoxifene in Postmenopausal Women with Osteoporosis
- (2010) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
- (2010) T. J. de Villiers et al. OSTEOPOROSIS INTERNATIONAL
- The Utility and Limitations of FRAX: A US Perspective
- (2010) Stuart L. Silverman et al. Current Osteoporosis Reports
- Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations
- (2010) Milica Nikitovic et al. Therapeutic Advances in Chronic Disease
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
- (2009) M. Rabaglio et al. ANNALS OF ONCOLOGY
- Compliance with Osteoporosis Treatment Guidelines in Postmenopausal Women
- (2009) Cary R Mountjoy et al. ANNALS OF PHARMACOTHERAPY
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Peak bone mineral density, lean body mass and fractures
- (2009) Annemieke M. Boot et al. BONE
- Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly
- (2009) René Rizzoli et al. BONE
- Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study
- (2009) Georgiana K. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
- (2009) Robert Lindsay et al. FERTILITY AND STERILITY
- Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture
- (2009) Erik Fink Eriksen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta
- (2009) Nick Bishop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
- (2009) Pierre D Delmas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
- (2009) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Characteristics and Medication Use among Premenopausal Women with Osteoporosis and Low BMD: The Experience of an Osteoporosis Referral Center
- (2009) Adi Cohen et al. JOURNAL OF WOMENS HEALTH
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy outcome following in utero exposure to bisphosphonates
- (2008) Shirley Levy et al. BONE
- Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
- (2008) David M. Reid et al. CANCER TREATMENT REVIEWS
- Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial)
- (2008) Alexandra Papaioannou et al. CHEST
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)
- (2008) Ian Chapman et al. CLINICAL ENDOCRINOLOGY
- Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment
- (2008) A SEBBA CLINICAL THERAPEUTICS
- Biodistribution and Plasma Protein Binding of Zoledronic Acid
- (2008) H. M. Weiss et al. DRUG METABOLISM AND DISPOSITION
- Osteoporosis in Men
- (2008) Sundeep Khosla et al. ENDOCRINE REVIEWS
- Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
- (2008) Gerardo Heiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment
- (2008) Barbara M Obermayer-Pietsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*
- (2008) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
- (2008) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Position Development Conference
- (2008) Sanford Baim et al. JOURNAL OF CLINICAL DENSITOMETRY
- A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System
- (2008) Brian A. Swiglo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate
- (2008) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Ten-Year Follow-Up of 3 Years of Oral Adjuvant Clodronate Therapy Shows Significant Prevention of Osteoporosis in Early-Stage Breast Cancer
- (2008) Tiina Saarto et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry
- (2008) E. M. Lewiecki et al. OSTEOPOROSIS INTERNATIONAL
- Vitamin D status and response to treatment in post-menopausal osteoporosis
- (2008) S. Adami et al. OSTEOPOROSIS INTERNATIONAL
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
- (2008) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?
- (2008) Celestia S Higano Nature clinical practice. Urology
- Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
- (2007) Steven Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
- (2006) Carolyn M. Klotzbuecher et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now